Department of Cardiology, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Front Endocrinol (Lausanne). 2021 Jul 28;12:708216. doi: 10.3389/fendo.2021.708216. eCollection 2021.
Thyroid function is closely involved in cardiovascular diseases. The free triiodothyronine (fT3) to free thyroxine (fT4) ratio has been reported as a risk factor for coronary artery disease, but its prognostic value in euthyroid patients with myocardial infarction with nonobstructive coronary arteries (MINOCA) remains unclear.
A total of 1162 euthyroid patients with MINOCA were enrolled and divided according to decreased tertiles of fT3/fT4 ratio. The study endpoint was major adverse cardiovascular events (MACE), including all-cause death, nonfatal MI, nonfatal stroke, revascularization, and hospitalization for unstable angina or heart failure. Kaplan-Meier, Cox regression, and receiver-operating characteristic analyses were performed.
Patients with lower fT3/fT4 tertile levels had a significantly higher incidence of MACE (10.0%, 13.9%, 18.2%; p=0.005) over the median follow-up of 41.7 months. The risk of MACE increased with the decreasing fT3/fT4 tertiles even after multivariate adjustment (tertile1 as reference, tertile2: HR 1.58, 95% CI: 1.05-2.39, p=0.030; tertile3: HR 2.06, 95% CI: 1.17-3.11, p=0.006). Lower level of fT3/fT4 ratio remained a robust predictor of MACE in overall (HR 1.64, 95% CI: 1.18-2.29, p=0.003) and in subgroups. When adding fT3/fT4 ratio [area under the curve (AUC) 0.61] into the thrombolysis in myocardial infarction (TIMI) risk score (AUC 0.69), the combined model (AUC 0.74) yielded a significant improvement in discrimination for MACE (ΔAUC 0.05, p=0.023).
Low level of fT3/fT4 ratio was strongly associated with a poor prognosis in euthyroid patients with MINOCA. Routine assessment of fT3/fT4 ratio may facilitate risk stratification in this specific population.
甲状腺功能与心血管疾病密切相关。游离三碘甲状腺原氨酸(fT3)与游离甲状腺素(fT4)比值已被报道为冠心病的危险因素,但在非阻塞性冠状动脉心肌梗死伴正常甲状腺功能(MINOCA)的甲状腺功能正常患者中的预后价值仍不清楚。
共纳入 1162 例甲状腺功能正常的 MINOCA 患者,并根据 fT3/fT4 比值的三分位降低进行分组。研究终点为主要不良心血管事件(MACE),包括全因死亡、非致死性心肌梗死、非致死性卒中等、血运重建和不稳定型心绞痛或心力衰竭住院治疗。进行 Kaplan-Meier 分析、Cox 回归分析和受试者工作特征(ROC)分析。
在中位随访 41.7 个月期间,fT3/fT4 三分位较低的患者发生 MACE 的发生率明显更高(10.0%、13.9%、18.2%;p=0.005)。即使在多变量调整后,MACE 的风险也随着 fT3/fT4 三分位的降低而增加(三分位 1 作为参考,三分位 2:HR 1.58,95%CI:1.05-2.39,p=0.030;三分位 3:HR 2.06,95%CI:1.17-3.11,p=0.006)。较低的 fT3/fT4 比值在总体人群(HR 1.64,95%CI:1.18-2.29,p=0.003)和亚组中仍然是 MACE 的可靠预测因子。当将 fT3/fT4 比值[曲线下面积(AUC)0.61]加入到心肌梗死溶栓治疗(TIMI)风险评分(AUC 0.69)中时,联合模型(AUC 0.74)对 MACE 的鉴别能力显著提高(AUC 差异 0.05,p=0.023)。
低水平的 fT3/fT4 比值与甲状腺功能正常的 MINOCA 患者的不良预后密切相关。常规评估 fT3/fT4 比值可能有助于对该特定人群进行风险分层。